BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210928
DTEND;VALUE=DATE:20211001
DTSTAMP:20260515T212900
CREATED:20210524T114659Z
LAST-MODIFIED:20210524T114953Z
UID:30324-1632787200-1633046399@www.pharmajournalist.com
SUMMARY:4th Annual Neuropsychiatric Drug Development Summit
DESCRIPTION:This last year has been a brutal reminder as to how crucial it is that we tackle the impending global mental health crisis and find a path towards successful neuropsychiatric drug development. \nWe are proud to be the industry’s definitive and unrivalled forum focused on encapsulating the recent clinical advances across this extremely arduous field. This timely meeting provides a much-needed platform for industry and academic thought leaders to: \n\nInvestigate new treatment paradigms to support schizophrenia patients with Sunovion\, Merck\, Cerevel and BioXcel\nStrive for useful biomarkers in clinical practice and explore novel electrophysiological biomarkers of synaptic plasticity in humans with Lundbeck\, Daniel Javitt and Takeda\nHear patient-centric approaches towards developing efficacious and engaging digital therapeutics with Thomas Insel\, MindMed\nDecipher the recent hype in psychedelics by evaluating new data emerging on hallucinogens with Psilera\, MAPS\, Eleusis\, ATAI and Perception Neuroscience\nDiscover the major advances in understanding neuroinflammation across CNS indications and how can we use this to help us further understand psychiatric conditions with Johnson & Johnson and Inmune Bio\n\nDon’t miss out and join over 80 of your peers at this timely event to take a step closer towards your ambitious goal of drastically improving the lives of individuals living with neuropsychiatric disorders. \nTo know more about 4th Annual Neuropsychiatric Drug Development Summit please click here.
URL:https://www.pharmajournalist.com/event/4th-annual-neuropsychiatric-drug-development-summit/
LOCATION:Online
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR